Gene · 54363
Papers4,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergistic effects of radiotherapy and immunotherapy: improving oncological outcomes. | Front Immunol | 2026 | 41716387 | PubTator, text mining | PubMed |
| Rational Design and Responsive Transdermal Cargo Delivery of Microneedles in the Treatment of Melanoma. | Int J Nanomedicine | 2026 | 41710366 | PubTator, text mining | PubMed |
| Nanobiosensor Based on Catalytic Palladium Nanoclusters and Oxidases for Bianalyte Electrochemical Determination: Glucose and Ethanol in Sweat. | Adv Healthc Mater | 2026 | 41709674 | PubTator, text mining | PubMed |
| Sensor ToolKit (STK): Compact Multiplexing Potentiostat for Point-of-Care Applications. | Anal Chem | 2026 | 41702413 | PubTator, text mining | PubMed |
| Metal-Phenolic Networks-Based Nanozyme Reprograms Tumor Metabolism and Immunosuppressive Microenvironment to Enhance Ferroptosis and Potentiate Cancer Immunotherapy. | ACS Nano | 2026 | 41701766 | PubTator, text mining | PubMed |
| Sequential Optimization of Multivariate Metal-Organic Framework Based Biocatalysis. | Small | 2026 | 41700626 | PubTator, text mining | PubMed |
| AI-integrated smartphone platform enables POC dual-channel glucose monitoring with an indicator-free nanozyme gel kit. | Biosens Bioelectron | 2026 | 41698866 | PubTator, text mining | PubMed |
| Functional Integrated Platform Initiates Cascade Reactions for Tooth-Extraction Wound Healing and Alveolar Bone Regeneration. | ACS Appl Mater Interfaces | 2026 | 41693112 | PubTator, text mining | PubMed |
| Visible-Light Driven Implantable Nanophotonic Biosensor for Continuous Glucose Monitoring via Metalloporphyrin Q-Band Modulation and Enzymatic Cascade Stabilization. | ACS Sens | 2026 | 41686153 | PubTator, text mining | PubMed |
| Janus-structured GOx-Fe/cu Nanozymes for broad-range glucose detection and Milk analysis. | Food Chem | 2026 | 41672014 | PubTator, text mining | PubMed |
| Metal Element-Doped Prussian Blue Enhanced Chemodynamic Therapy and Imaging of Breast Cancer. | ACS Appl Bio Mater | 2026 | 41666388 | PubTator, text mining | PubMed |
| A metal-free cascade nanoreactor reprograms the cystine-glutathione axis for disulfidptosis-pyroptosis therapy. | Acta Biomater | 2026 | 41662918 | PubTator, text mining | PubMed |
| A polymeric triple-enzyme nanoparticle by light activatable crosslinking for cascade catalytic therapy of osteosarcoma. | Bioact Mater | 2026 | 41660383 | PubTator, text mining | PubMed |
| Re-engineering insulin for oral delivery: structural modifications, advanced formulation strategies, and future directions. | Drug Deliv | 2026 | 41642241 | PubTator, text mining | PubMed |
| Unlocking the potential of mesoporous silica nanoparticles: balancing biomedical applications and safety concerns. | Drug Deliv | 2026 | 41631692 | PubTator, text mining | PubMed |
| A ratiometric fluorescent dual-mode amplification nanosensor based on pH and oxygen testing for ultrasensitive glucose detection. | Mikrochim Acta | 2026 | 41627376 | PubTator, text mining | PubMed |
| Capsule confined cascade reaction generating long-lasting and intensive chemiluminescence. | Anal Bioanal Chem | 2026 | 41615428 | PubTator, text mining | PubMed |
| An All-in-One Nanozyme for Synergistic Diabetic Wound Therapy: NIR-Augmented NO Release and Microenvironment Modulation. | Adv Healthc Mater | 2026 | 41588818 | PubTator, text mining | PubMed |
| Heterogeneous Magnetic Resonance Nanoprobe for Assisting Liver Fibrosis Three-Dimensional Reconstruction and Cascaded Therapy. | ACS Nano | 2026 | 41579096 | PubTator, text mining | PubMed |
| Tri-mode fluorescence/colorimetric/strip aptasensor with CRISPR/Cas12a-driven cascade strategy for mycotoxin. | Curr Res Food Sci | 2026 | 41568343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54363/papers?page=9